Skip to main content

Radiotherapy

Question for Department of Health

UIN 64143, tabled on 17 February 2017

To ask the Secretary of State for Health, what clinical evidence available after 2011 was considered by NHS England for inclusion in the evidence summary for Selective Internal Radiation Therapy under the Commissioning through Evaluation scheme.

Answered on

27 February 2017

The journal articles listed below became available after 2011 and were included in the Selective Internal Radiation Therapy evidence review undertaken by NHS England in 2013:

- Moreno-Luna LE, Yang JD, Sanchez W et al. Efficacy and safety of transarterial radioembolization versus chemoembolization in patients with hepatocellular carcinoma. Cardiovasc Intervent Radiol 2012 Oct 24; ePub doi: 10.1007/s00270-012-0481-2.

- Iñarrairaegui M, Pardo F, Bilbao JI et al. Response to radioembolization with yttrium-90 resin microspheres may allow surgical treatment with curative intent and prolonged survival in previously unresectable hepatocellular carcinoma. Eur J Surg Oncol 2012; 38: 594–601.

- Xie F, Zang J, Guo X et al. Comparison of transcatheter arterial chemoembolization and microsphere embolization for treatment of unresectable hepatocellular carcinoma: a meta-analysis. J Cancer Res Clin Oncol 2012; 138: 455‒462.

- Sulpice L, Rayar M, Boucher E, Pracht M, Meunier B, Boudjema K. Treatment of recurrent intrahepatic cholangiocarcinoma Br J Surg. 2012 Dec;99(12):1711-7.

- Hoffmann RT, Paprottka PM, Schön A et al. Transarterial hepatic yttrium-90 radioembolization in patients with unresectable intrahepatic cholangiocarcinoma: factors associated with prolonged survival. Cardiovasc Interv Radiol 2012; 35: 105–116.

- Shaheen M, Hassanain M, Aljiffry M et al. Predictors of response to radio-embolization (TheraSphere®) treatment of neuroendocrine liver metastasis. HPB 2012; 14: 60–66.

- Memon K, Lewandowski RJ, Mulcahy MF et al. Radioembolization for neuroendocrine liver metastases: Safety, imaging, and long-term outcomes. Int J Radiat Oncol Biol Phys 2012; 83: 887–894.

- Bester L, Meteling B, Pocock N et al. Radioembolization versus standard care of hepatic metastases: Comparative retrospective cohort study of survival outcomes and adverse events in salvage patients. J Vasc Interv Radiol 2012; 23: 96–105.